跳至主要内容
临床试验/DRKS00025457
DRKS00025457招募中未知

Major depression as a metabolic disorder: The role of oxygen homeostasis and mitochondrial bioenergetics in depression etiology and therapy - MitO2Health

Department of Clinical and Biological Psychology, Ulm University0 个研究点目标入组 300 人开始时间: 2021年7月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • A diagnosis of major depressive disorder according to DSM-5; accepted psychological comorbidities: anxiety disorders, and somatoform disorders. Stable medication is permitted.

排除标准

  • High suicidality, PTSD and complex PTSD, Borderline personality disorder, eating disorders, obsessive compulsive disorder, bipolar disorder, schizophrenia or a history of psychotic disorders, acute substance-related disorder, organic mental disorder, pregnancy and nursing, neurological diseases, immunological and endocrine disorders, autoimmune diseases such as chronic viral infections, rheumatoid arthritis, cardiovascular comorbidities, cancer, chronic obstructive pulmonary diseases, Body Mass Index (BMI) > 30, usage of certain intrauterine devices (eg. Mirena)

研究者

发起方
Department of Clinical and Biological Psychology, Ulm University

相似试验